Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review

被引:0
作者
Anke L. Stuurman
Marije Vonk Noordegraaf-Schouten
Femke van Kessel
Anouk M. Oordt-Speets
Andreas Sandgren
Marieke J. van der Werf
机构
[1] Pallas health research and consultancy BV,
[2] European Centre for Disease Prevention and Control (ECDC),undefined
来源
BMC Infectious Diseases | / 16卷
关键词
Tuberculosis; Latent tuberculosis; Treatment initiation; Treatment adherence; Treatment completion; Risk groups;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 287 条
[1]  
Lillebaek T(2002)Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection J Infect Dis 185 401-4
[2]  
Dirksen A(2009)The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol 7 845-55
[3]  
Baess I(1999)Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project JAMA 282 677-86
[4]  
Strunge B(2014)Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews BMC Infect Dis 14 281-97
[5]  
Thomsen VO(2012)Patient education and counselling for promoting adherence to treatment for tuberculosis Cochrane Database Syst Rev 5 CD006591-94
[6]  
Andersen AB(2005)Adherence to medication N Engl J Med 353 487-93
[7]  
Barry CE(2013)Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB Cochrane Database Syst Rev 7 CD007545-50
[8]  
Boshoff HI(2012)The use of incentives to reinforce medication adherence Prev Med 55 S86-93
[9]  
Dartois V(2011)GRADE guidelines 6. Rating the quality of evidence—imprecision J Clin Epidemiol 64 1283-5
[10]  
Dye C(2012)Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis BMC Res Notes 5 52-82